Treatment of lupus nephritis with cyclosporine - An outcome analysis

Kidney and Blood Pressure Research

Volumn 30, Issue 2, 2007, Pages 124-128

  Rihova, Zuzana ^a   Vankova, Zdenka ^a   Maixnerova, Dita ^a   Dostal, Ctibor ^a   Jancova, Eva ^a   Honsova, Eva ^b   Merta, Miroslav ^a   Rysava, Romana ^a   Tesar, Vladimir ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Cyclosporine; Lupus nephritis; Systemic Lupus Erythematosus Disease Activity Index SLEDAI

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE FREE INTERVAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GINGIVA HYPERTROPHY; HIRSUTISM; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE THERAPY; MALE; MONOTHERAPY; NEPHROTOXICITY; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RELAPSE; REMISSION; TREATMENT OUTCOME;

ADULT; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; LUPUS NEPHRITIS; MALE; TREATMENT OUTCOME;

EID: 34247568504     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101448     Document Type: Article

References (16)

1. Rothfield N: Clinical features of SLE; in Kelley WN et al (eds): Textbook of Rheumatology. Philadelphia, Saunders, 1981.
2. Dooley MA, Falk RJ: Immunosuppressive therapy of lupus nephritis. Lupus 1998;7: 630-634.
3. Radharkrishnan J, Kunis CL, D'Agati VD, et al: Cyclosporin treatment of lupus membranous nephropathy. Clin Nephrol 1994;42: 147-154.
4. Hallegua D, Wallace DJ, Metzger AL, et al: Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature. Lupus 2000;9:241-251.
5. Yin PD, Yang XY: A clinical study on low dose cyclosporin A in the treatment of lupus nephritis. Zhonghua Nei Ke Za Zhi 1994;33: 684-686.
6. Favre H, Miescher PA, Huang YP, et al: Cyclosporin in the treatment of lupus nephritis. Am J Nephrol 1989;9:57-60.
7. Dostal C, Tesar V, Rychlik I, et al: Effect of one year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study. Lupus 1998;7:29-36.
8. Tam LS, Li EK, Leung CB, et al: Long-term treatment of lupus nephritis with cyclosporin A. QJM 1998;91:573-580.
9. Dostal C, Tesar V, Rysava R, et al: Cyclofalune (2002) lupus nephritis-randomized controlled multicentric therapeutic comparation with cyclosporin A versus cyclophosphamide: running evaluation. Ann Rheum Dis 2004;63(suppl 1):223.
10. Bombardieri C et al and Comittee on Prognostic Studies in SLE: Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-640.
11. Cattran DC: Cyclosporine in the treatment of idiopathic focal segmental glomerulosclerosis. Semin Nephrol 2003;23:234-241.
12. Cattran DC: Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy. Semin Nephrol 2003;23:272-277.
13. Feutren G, Querin S, Noel LH, et al: Effects of cyclosporin in severe lupus erythematosus. J Pediatr 1987;111:1063-1068.
14. Contreras G, Pardo V, Leclercq B, et al: Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004;350:971-980.
15. Lenz O, Contreras G: Treatment options for severe lupus nephritis. Arch Immunol Ther Exp 2004;52:356-365.
16. Bogdanovic R, Nikolic V, Pasic S: Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 2004;19:36-44.